Prosecution Insights
Prosecution Insights
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (60%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARMSTRONG, JONATHAN D | 1 | 53.9% | +3.6% |
| BROWE, DAVID | 1 | 26.2% | +27.7% |
| SWITZER, JULIET CAROLINE | 1 | 42.4% | +53.8% |
| CRAIG, KAILA ANGELIQUE | 1 | 32.8% | +26.5% |
| FRITCHMAN, REBECCA M | 1 | 45.7% | +35.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18035358 | SYSTEMS FOR BUCCAL RELEASE OF PROTEINS | BROWE, DAVID | 3d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18007254 | POLYSACCHARIDE COMPRISING A CHELATING GROUP SOLUBLE AT PHYSIOLOGICALPH AND USE THEREOF | CRAIG, KAILA ANGELIQUE | 43d overdue |
| 18035239 | USE OF TORQUE TENO VIRUS (TTV) AS A MARKER TO DETERMINE THE PROLIFERATIVE CAPACITY OF T LYMPHOCYTES | SWITZER, JULIET CAROLINE | 31d overdue |
| 18035358 | SYSTEMS FOR BUCCAL RELEASE OF PROTEINS | BROWE, DAVID | 3d overdue |
| 17766155 | METHOD FOR DETERMINING AN INDIVIDUAL ABILITY TO RESPOND TO A STIMULUS | FRITCHMAN, REBECCA M | 5d |
| Art Unit | Apps |
|---|---|
| 3645 | 1 |
| 1617 | 1 |
| 1682 | 1 |
| 1618 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18853607 | METHOD AND APPARATUS FOR ULTRASONIC EVALUATION OF AN ISOLATED ORGAN | ARMSTRONG, JONATHAN D | 3645 | §103 | Non-Final OA | 76d | Pending | Oct 02, 2024 |
| 18035358 | SYSTEMS FOR BUCCAL RELEASE OF PROTEINS | BROWE, DAVID | 1617 | §103§112 | Final Rejection | 3d overdue | Pending | May 04, 2023 |
| 18035239 | USE OF TORQUE TENO VIRUS (TTV) AS A MARKER TO DETERMINE THE PROLIFERATIVE CAPACITY OF T LYMPHOCYTES | SWITZER, JULIET CAROLINE | 1682 | §103 | Final Rejection | 31d overdue | Pending | May 03, 2023 |
| 18007254 | POLYSACCHARIDE COMPRISING A CHELATING GROUP SOLUBLE AT PHYSIOLOGICALPH AND USE THEREOF | CRAIG, KAILA ANGELIQUE | 1618 | §103DP | Final Rejection | 43d overdue | Pending | Jan 27, 2023 |
| 17766155 | METHOD FOR DETERMINING AN INDIVIDUAL ABILITY TO RESPOND TO A STIMULUS | FRITCHMAN, REBECCA M | 1758 | §103 | Non-Final OA | 5d | Pending | Apr 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial